Literature DB >> 22074983

Exact two-stage designs for phase II activity trials with rank-based endpoints.

Gregory E Wilding1, Guogen Shan, Alan D Hutson.   

Abstract

Features common to phase II clinical trials include limited knowledge of the experimental treatment being evaluated, design components reflecting ethical considerations, and small to moderate sample sizes as a result of resource constraints. It is for these reasons that there exist many two-stage designs proposed in the literature for use in this context. The majority of these designs are for binary endpoints and based on exact probability calculations, or are for continuous endpoints and rooted in asymptotic approximations to the null distribution. We present exact two-stage Mann-Whitney designs in the context of two-arm randomized clinical trials. In addition to describing the designs, we present tables of decision rules under a variety of assumed realities for use in trial planning.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 22074983     DOI: 10.1016/j.cct.2011.10.008

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  6 in total

1.  Some tests for detecting trends based on the modified Baumgartner-Weiβ-Schindler statistics.

Authors:  Guogen Shan; Changxing Ma; Alan D Hutson; Gregory E Wilding
Journal:  Comput Stat Data Anal       Date:  2013-01       Impact factor: 1.681

2.  Homogeneity test for correlated binary data.

Authors:  Changxing Ma; Guogen Shan; Song Liu
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

3.  A new powerful nonparametric rank test for ordered alternative problem.

Authors:  Guogen Shan; Daniel Young; Le Kang
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

4.  Statistical advances in clinical trials and clinical research.

Authors:  Guogen Shan; Sarah Banks; Justin B Miller; Aaron Ritter; Charles Bernick; Joseph Lombardo; Jeffrey L Cummings
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-14

5.  Two-stage optimal designs with survival endpoint when the follow-up time is restricted.

Authors:  Guogen Shan; Hua Zhang
Journal:  BMC Med Res Methodol       Date:  2019-04-03       Impact factor: 4.615

6.  Effects of dose change on the success of clinical trials.

Authors:  Guogen Shan; Aaron Ritter; Justin Miller; Charles Bernick
Journal:  Contemp Clin Trials Commun       Date:  2022-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.